With new technologies and discoveries advancing rapidly, the life sciences sector is growing faster than ever. BioTech, pharmaceutical, and MedTech companies need to make sure that their fundraising, innovation, and strategic partnership efforts are conducted smoothly and at maximum efficiency. When it comes to starting and building a medical device company, a strong patent strategy tied to business goals can be the driving force behind venture capital investment, strategic collaborations, mergers and acquisitions. In order to safeguard its intellectual property (IP), every MedTech startup should consider protecting and leveraging its innovations as soon as possible.
In this webinar, join in a discussion between Dr Andrew T. Serafini, Partner and Mr Patrick Ngeim, Senior Associate at Kilpatrick Townsend on strategies for protecting innovations utilising software inventions in the U.S., including Artificial Intelligence (AI) innovation in the life science space. They will be addressing some of the best practices for overcoming various US Patent and Trademark Office (USPTO) hurdles for patentability, its requirements and strategies to meet the current demands.
Key Takeaways:
- Best practices for overcoming hurdles for patentability
- Strategies to meet the current “patentability” requirements
- Increase in USPTO AI patent filings
- IP strategies regarding patent protections for AI and other areas in the life sciences
- Training of an AI, the use of the AI, and/or the specific models of the AI
This event is brought to you by
CATALYST in conjunction with
Centre for Technology and Development (CTeD) at Duke-NUS Medical School. Click
here to Register.
